You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Litigation Details for Veloxis Pharmaceuticals, Inc. v. Accord Healthcare, Inc. (D. Del. 2022)

✉ Email this page to a colleague

« Back to Dashboard

Veloxis Pharmaceuticals, Inc. v. Accord Healthcare, Inc. (D. Del. 2022)

Docket	⤷ Sign Up	Date Filed	2022-07-07
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To
Jury Demand	None	Referred To
Parties	VELOXIS PHARMACEUTICALS, INC.
Patents	10,166,190; 8,664,239; 8,685,998; 9,549,918
Attorneys	Jeremy A. Tigan
Firms	Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

Small Molecule Drugs cited in Veloxis Pharmaceuticals, Inc. v. Accord Healthcare, Inc.

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Details for Veloxis Pharmaceuticals, Inc. v. Accord Healthcare, Inc. (D. Del. 2022)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2022-10-14	21	Patent/Trademark Report to Commissioner of Patents	Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,685,998 B2 ;9,549,918 B2 ;10,166,190 B2 ;… 7 July 2022 1:22-cv-00909 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2022-07-07	4	Patent/Trademark Report to Commissioner of Patents	of Patents and Trademarks for Patent/Trademark Number(s) 8,685,998 B2 ; 9,549,918 B2; 10,166,190 B2; … 7 July 2022 1:22-cv-00909 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2023-05-04	61	Stipulation-General (See Motion List for Stipulation to Extend Time)	Order Concerning Claim Construction of U.S. Patent Nos. 8,685,998; 9,549,918; 10,864,199; 11,110,081; 11,123,331… 7 July 2022 1:22-cv-00909 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2023-05-05	62	SO ORDERED	Order Concerning Claim Construction of U.S. Patent Nos. 8,685,998; 9,549,918; 10,864,199; 11,110,081; 11,123,331… 7 July 2022 1:22-cv-00909 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2023-05-05	63	Claim Construction Chart	U.S. Patent No. 8,685,998, # 6 Exhibit F - Portions of File History of U.S. Patent No. 8,664,239)(Tigan…Attachments: # 1 Exhibit A - U.S. Patent No. 10,864,199, # 2 Exhibit B - U.S. Patent No. 11,110,081, # 3 Exhibit…History of U.S. Patent No. 10,864,199, # 4 Exhibit D - Portions of File History of U.S. Patent No. 11,110,… 7 July 2022 1:22-cv-00909 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.